HPV Detection: Current Status and Future Goals for Personalized Prevention

View Sample PDF

Author(s): Aris Spathis (University General Hospital “ATTIKON”, Greece), Stavros Archondakis (401 Army General Hospital, Greece)and Petros Karakitsos (University General Hospital “ATTIKON”, Greece)
Copyright: 2013
Pages: 19
Source title: E-Health Technologies and Improving Patient Safety: Exploring Organizational Factors
Source Author(s)/Editor(s): Anastasius Moumtzoglou (Hellenic Society for Quality & Safety in Healthcare and P. & A. Kyriakou Children's Hospital, Greece)and Anastasia N. Kastania (Athens University of Economics and Business, Greece)
DOI: 10.4018/978-1-4666-2657-7.ch013

Keywords: Health Information Systems / Medical Information Science Reference / Medicine & Healthcare

Purchase

View HPV Detection: Current Status and Future Goals for Personalized Prevention on the publisher's website for pricing and purchasing information.

Abstract

Human papilloma viruses (HPVs) have been acknowledged to be the leading risk factor of cervical intra-epithelial lesion creation (CIN) and cervical cancer development (CxCa), while recently, a vaccine protecting from the most commonly HPV types found in CxCa has been produced and introduced in vaccination schemes across the globe. Many different techniques have been created and utilized in HPV detection and monitoring with a vast amount of them being commercialized and few of them integrated in screening strategies. However, there has been no effort in combining data from all the different techniques and provide efficient patient triaging schemes, since, apart from the obvious increase of patient cost, the amount of data and its interpretation in patient management has been impossible.

The IRMA Community

Research IRM

HPV Detection: Current Status and Future Goals for Personalized Prevention

Purchase

Abstract

Related Content

IRMA Sponsors